Quick Takeaways
- Mark E. Strome filed SCHEDULE 13D/A for Zivo Bioscience Common Stock, par value $.001 per share (ZIVO).
- Disclosed ownership: 12%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"Mark E. Strome disclosed 12% ownership in Zivo Bioscience Common Stock, par value $.001 per share (ZIVO) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mark E. Strome | 12% | 472,942 | 194,303 | 278,639 | /s/ Mark E. Strome | Mark E. Strome | 0000919484 |
| Strome Group, Inc. | 7.1% | 278,639 | 0 | 278,639 | /s/ Mark E. Strome | Mark E. Strome/President | 0001355526 |
| Strome Investment Management, LP | 7.1% | 278,639 | 0 | 278,639 | /s/ Mark E. Strome | Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP | 0000936711 |
| Strome Mezzanine Fund, LP | 0% | 0 | 0 | 0 | /s/ Mark E. Strome | Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP, surviving entity of merger | 0001713153 |
| Strome Mezzanine Fund II, LP | 6.8% | 266,198 | 0 | 266,198 | /s/ Mark E. Strome | Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP | 0001978360 |